We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




CT Myocardial Perfusion Tool Helps Generate Faster, Safer Cardiac Diagnoses

By HospiMedica International staff writers
Posted on 26 Mar 2014
A computed tomography (CT) system’s application allows clinicians to visualize myocardial ischemia.

To optimize cardiac diagnoses with simplified dose reduction technology, Toshiba Medical Systems (Tokyo, Japan) reported the US Food and Drug Administration (FDA) clearance of its CT myocardial perfusion capability. More...
Available on Toshiba’s Aquilion One and Aquilion One ViSION Edition CT systems, the myocardial perfusion features allows clinicians to visualize myocardial ischemia with CT, providing a clinical and subsystem to streamline workflow.

The myocardial perfusion tool on Toshiba’s 320-detector-row CT scanner visualizes blood flow and anatomy within the coronary arteries to help determine the viability of the heart muscle. This enables clinicians to provide more rapid and more effective decisions on whether to undergo revascularization of coronary blockages. Toshiba’s CT Myocardial Perfusion puts patient experience first with shorter exam times and substantially lower radiation exposure, when compared with standard coronary artery disease (CAD) evaluation techniques.

“Heart disease has remained the number one cause of death in the United States, according to the Centers for Disease Control and Prevention [Atlanta, GA, USA], and new CT technology is helping diagnose cardiac disease sooner,” said Satrajit Misra, senior director, CT business unit, Toshiba. “The Aquilion One’s ability to capture the entire heart in a single rotation and its Myocardial Perfusion capability allow clinicians to make better decisions on treatment. Additionally, Toshiba’s simplified dose reduction technology, AIDR [adaptive iterative dose reduction] 3D, ensures that CT dose and safety is not a choice hospitals or patients should have to make.”

Toshiba will present its myocardial perfusion technology at the 2014 American College of Cardiology (ACC) annual meeting in Washington DC (USA), March 29–April 2, 2014.

Related Links:

Toshiba Medical Systems



Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Glucose Meter
StatStrip®
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Sphere-9 is the first all-in-one mapping and ablation, large-tip focal, dual-energy catheter to be CE marked for ventricular ablation (Photo courtesy of Medtronic)

Dual-Energy Mapping and Ablation Catheter Receives CE Mark for Ventricular Arrhythmias

Ventricular arrhythmias, including ventricular tachycardia and premature ventricular complexes, can be life-threatening and often occur in patients with advanced heart disease. Although catheter ablation... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.